TrialClinical epigenetics2019

Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia.

Woonbok Chung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.